Cosmetics tallow derivative use sanctioned regardless of countries' BSE status by FDA cmte.
This article was originally published in The Rose Sheet
Executive Summary
TALLOW DERIVATIVE USE REGARDLESS OF COUNTRY's BSE STATUS RECOMMENDED narrowly by FDA's Transmissible Spongiform Encephalopathies Advisory Committee. At a meeting in Bethesda, Md. April 15-16, the committee voted 6-5 to allow sourcing of tallow derivatives in cosmetics, food, nutritional supplements and drugs "from any country, irrespective of BSE status," according to Committee Chairman Paul Brown, MD, National Institute of Neurological Disorders & Stroke. The panel's recommendation would reverse current FDA guidelines, which have established that bovine source materials for the manufacturing of tallow derivatives should not come from countries where cattle have been infected with BSE. The committee's proposal will be taken under advisement by FDA.
You may also be interested in...
U.S. Cosmetic Products Safe From BSE-Infected Cow – FDA
Cosmetics manufactured in the U.S. are highly unlikely to be contaminated by rendered products from the cow in Washington state that tested positive for bovine spongiform encephalopathy last month, according to FDA
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program